SHAZ Bounces 16.85% Off Oversold Lows as Analysts Split $40 to $124

A Bounce, Not a Breakout

SHAZ climbed 16.85% over roughly 20 hours to $70.94, but the honest read is a reversal off oversold levels, not a breakout on news. The stock went into July 20 down nearly 20% on the week and about 21% on the month, trading a $60.20–$68.00 range and changing hands near $61.16 before this move. Snapping back to $70.94 is exactly the kind of swing a high-beta name makes after it gets sold too hard — SharonAI carries a beta near 6, so a thin book cuts both ways. There is no company announcement dated to this window; the last real headline is five days old. On the HIP-3 perp only about $353K changed hands in 24h, so it does not take much size to move the mark. This is positioning unwinding a selloff, not new information re-rating the story.

The $1.32B Deal Doing the Heavy Lifting

Strip out the day-to-day chop and the real story is the stack of contracts SharonAI keeps signing. On July 16 the company announced a US$1.32 billion, five-year cloud computing agreement with an unnamed global AI lab, to be deployed across data center capacity in New Zealand with revenue starting in the first half of 2027. That single contract is worth more than the company's entire ~$1 billion market cap, and it lifts contracted AI-factory capacity to 116MW of a planned 132MW, with more than 62,000 NVIDIA GPUs targeted by mid-2027. The catch is timing: none of that revenue hits the income statement until 2027, and last quarter SharonAI booked just $0.29 million in revenue against a $1.43 per-share loss. The bull case is entirely forward-looking — you are buying a backlog, not a business, and the market reprices that backlog every session.

Wall Street Can't Agree

Few names show this much disagreement on the sell side. B. Riley initiated at Buy with a $124 target on July 9, and Compass Point reiterated Buy at $90 on the Nvidia collaboration. Against that, Cantor Fitzgerald sits at just $40, and — on the very day this perp turned higher — Wall Street Zen cut the stock from Hold to Sell, leaving an $84.67 average target. A $40-to-$124 spread tells you nobody actually knows what a pre-revenue neocloud with a giant backlog and an even bigger dilution stack is worth. It also fits the supply overhang we flagged last week: every rally has to climb over registered convertible and warrant shares, and Simply Wall St already called the stock fully priced after a very large run. For a beta-6 name with no fresh news, split analysts, and supply overhead, 15–20% swings on nothing are the base case, not the exception.